Executive summary On July 21, 2020, the United States (U.S.) government, Pfizer, and BioNTech signed a contract, known as a Statement of Work (SOW), for the rapid development of and obtaining regulatory licensure for a COVID-19 vaccine by October 31, 2020, a few days prior to the November 3, 2020, […]
Dr Naomi Wolf: Perjurious Testimony of Dr. Walensky’s ‘Anomalous Science’ of Failure of Efficacy
Dr Naomi Wolf: Perjurious Testimony of Dr. Walensky’s ‘Anomalous Science’ of Failure of Efficacy.
Report 73: Pfizer Knew by November 2020 That Its mRNA COVID Vaccine Was Neither Safe Nor Effective. Here Is What Pfizer’s Employees and Contractors Knew and When They Knew It.
Introduction Through the review of two documents – Pharmacovigilance Plan for Biologic License Application #125742 Of Covid-19 mRNA vaccine (nucleoside modified) (BNT162b2, PF-07302048) and 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021 – referred to below as “PV” and “5.3.6,” the contributors to this […]
Follow-Up to “NAATs Used in Pfizer Clinical Trial to Test Asymptomatic Patients Despite Not Being Approved (or Even Emergency Use Authorized) for Asymptomatic Testing.”
Addendum: Since publication of this piece on April 25, 2023, a new Pfizer document tranche (dated April 3, 2023, but available publicly in late April 2023) has been released, and it included, “Report on Method Validation of a Cepheid Xpert® Xpress PCR Assay to Detect SARS-CoV-2.” The validation report states: “This report […]
Report 59: The Flawed Trial of Pfizer’s COVID-19 mRNA “Vaccine.” 90% of Original Placebo Group Received at Least One mRNA Injection by March 2021.
The clinical trial of Pfizer’s mRNA “vaccine” did not prove the mRNA injection is safe and effective, despite Pfizer’s claims to the contrary. In fact, Pfizer stopped collecting useful data long before the planned end date of the clinical trial. Based on an inaccurate diagnostic test confirming COVID-19 in a […]
Pfizer/BioNTech Trial – A failed yet in depth attempt to reproduce the NEJM & FDA efficacy figures
Study version 1.3, published on 2022-12-09 To view the full version with graphics, please click here. Introduction We review, in this article, a list of problems in the Pfizer/BioNTech C4591001 Trial, which came out in our attempts to reproduce the results provided by the study. Using the sponsor’s data communicated to […]
“170 Patients That Changed Everything” – Spectator | Australia
Few people realise that the Emergency Use Authorisation (EUA) of the Pfizer-BioNTech Covid-19 Vaccine/BNT162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims. There has not been much […]
How an illusion of efficacy can be established for any treatment
In this video, Norman Fenton explains how to create the illusion of high efficacy for a treatment with no efficacy at all. This example features a placebo in place of a vaccine and compares the manipulation of numbers to create the appearance of efficacy. Don’t miss it! “In determining […]
Videos: How Pfizer’s EUA Was Granted Based on Fewer Than 0.4% of Clinical Trial Participants
The videos linked below offer audio-visual explanations of Report 42: Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA. These videos show: 1. The pivotal Pfizer trial upon which the Emergency Use Authorization (EUA) for the COVID -19 vaccines […]
Report 42: Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA.
Locations of the 170 Pfizer Clinical Trial Patients Used to Gain Emergency Use Authorization (EUA) for Its COVID mRNA Vaccine. Courtesy of OPENVAET.org For audio-visual explanations of this report, please see these videos. So much has been written about the pivotal Pfizer Trial for COVID-19 (C4591001), that it is sometimes […]